Genesis Therapeutics Announces Strategic Collaboration with Lilly to Discover Novel Therapies Using the Genesis Molecular AI Platform
Genesis to Receive $20 Million in Upfront Cash with Potential Total Value of $670 Million…
Month: May 2022
Denny’s Replaces On-Premise Contact Center Solution with 3CLogic
“America’s Diner” deploys ServiceNow-centric voice solution to deliver faster IT and HR employee services through…
Zayo and Equinix Successfully Complete First Data Center 400G Trial, Connecting Sites in London and Paris
LONDON–(BUSINESS WIRE)–Zayo Group Holdings, Inc., a leading global provider of fiber-based communications solutions, and Equinix,…
Allnet.Italia and TECNEL support seamless maritime communications for SAIPEM with Spectralink solutions
Allnet.Italia and TECNEL develop ATEX compliant maritime-proof communications for leading Energy and Utility company SAIPEM…
Cerillion strengthens B2B credentials with latest product suite release and new software editions
London, 3rd May 2022 – Cerillion (AIM: CER) today announced the general availability of Cerillion…
reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase 1; transitioning into Phase 2a
PRESS RELEASE reMYND’s novel Alzheimer program reports excellent brain exposure and safety profile in Phase…
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
Phase 3 ENHANCE-2 trial on target to report top-line COPD data in Q3 2022 James…
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) — Curium announced today it has successfully enrolled…
Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder
QUVIVIQ™▼ is indicated for the treatment of adult patients with insomnia characterized by symptoms present…
ZOLEO Inc. Announces Expansion to Europe
Award-winning ZOLEO® global satellite communicator now available in Norway, Finland, Sweden, Denmark and the United…
New World Partners with Pure Spirits to Create Augmented Reality Experience at Formula 1 Miami
Toronto, Ontario–(Newsfile Corp. – May 3, 2022) – Graph Blockchain Inc. (CSE: GBLC) (OTC Pink: REGRF)…
Coinsfera Is the First Company to Offer Buying Property in Dubai with Bitcoin
Dubai, United Arab Emirates–(Newsfile Corp. – May 3, 2022) – Coinsfera becomes the first company…
Agendia Demonstrates Accessibility and Affordability of MammaPrint® and BluePrint® in Europe at ESMO Breast Cancer 2022
Next-generation sequencing version of MammaPrint and BluePrint enables decentralized testing in CE-mark jurisdictions like Germany…
Taoiseach cuts ribbon at newly launched Blancco office in Cork City Centre
New 34-person site will become centre of excellence in research and development to help fuel…
Tenet Year-end 2021 Audited Financial Results Confirm Growth Trajectory with Revenues of $103.6M for the Year
Toronto, Ontario–(Newsfile Corp. – May 2, 2022) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Novra Announces 2021 Financial Results
Winnipeg, Manitoba–(Newsfile Corp. – May 2, 2022) – Novra Technologies Inc. (TSXV: NVI) (“Novra”) has…
CORRECTING and REPLACING NuScale Power Completes Merger with Spring Valley Acquisition Corp. to Create World’s First and Only Publicly Traded Provider of Transformational Small Modular Nuclear Reactor Technology
Combined company expected to have enterprise value of approximately $1.9 billion; will commence trading on…
California American Water Applies for New Revenue to Fund Infrastructure and Service Improvements
Request reinforces company’s commitment to providing safe, reliable and affordable water and wastewater service SAN…
Aquarius AI Inc. Announces That It Anticipates a Temporary Delay in the Filing of Financial Statements and Application for Management Cease Trade Order
Vancouver, British Columbia–(Newsfile Corp. – May 2, 2022) – Aquarius AI Inc. (CSE: AQUA) (“AQUA”…
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…